1. Home
  2. DJCO vs EVO Comparison

DJCO vs EVO Comparison

Compare DJCO & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daily Journal Corp. (S.C.)

DJCO

Daily Journal Corp. (S.C.)

HOLD

Current Price

$484.32

Market Cap

706.2M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.44

Market Cap

821.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DJCO
EVO
Founded
1987
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Newspapers/Magazines
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
706.2M
821.2M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
DJCO
EVO
Price
$484.32
$2.44
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
89.6K
111.6K
Earning Date
02-17-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
43.50
N/A
EPS
N/A
N/A
Revenue
$41,384,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$348.63
$2.31
52 Week High
$674.75
$4.80

Technical Indicators

Market Signals
Indicator
DJCO
EVO
Relative Strength Index (RSI) 41.52 30.07
Support Level $481.78 N/A
Resistance Level $495.51 $3.78
Average True Range (ATR) 33.92 0.09
MACD -2.38 -0.05
Stochastic Oscillator 25.46 14.38

Price Performance

Historical Comparison
DJCO
EVO

About DJCO Daily Journal Corp. (S.C.)

Daily Journal Corp publishes newspapers and websites covering California and Arizona and produces several specialized information services. The company operates in two segments: Traditional business and Journal Technologies which includes Journal Technologies, Inc. and Journal Technologies (Canada) Inc. It also serves as a newspaper representative specializing in public notice advertising. The majority of revenue is generated from the Traditional segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: